Neurogenic Blepharoptosis After Medial Orbital Wall Reconstruction

Copyright © 2020 by Mutaz B. Habal, MD..

ABSTRACT: Neurogenic blepharoptosis after orbital wall reconstruction is a rare complication. It can either present as an isolated blepharoptosis, or accompany with other ocular symptoms. The authors introduce 4 cases of post-operative neurogenic blepharoptosis after reconstruction of medial orbital wall via transcaruncular approach.Immediately after the surgery, 2 adolescent patients experienced unilateral islolated complete blepharoptosis with no other ocular symptoms. The other 2 adult patients presented unilateral complete blepharoptosis accompanied by lateral displacement of the globe and evident extraocular movement limitations. The 2 adolescent patients were observed with no particular treatment, whereas the other 2 adult patients were treated with intravenous systemic steroids. The blepharoptosis symptom began to improve at 2 weeks post-operatively and completely recovered within 3 to 4 months in all patients, while the globe displacement and extraocular movement limitation started to improve at 4 weeks after the surgery and fully recovered within 6 months.Although neurogenic blepharoptosis after medial orbital wall reconstruction is a very rare complication, it can be critical once it occurs. According to the author's experience, it fortunately shows a favorable clinical course of spontaneous recovery. Post-operative neurogenic blepharoptosis usually recovers between 2 weeks and 4 months and other ocular symptoms related to oculomotor nerve injury recovers within 6 months after the surgery.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:32

Enthalten in:

The Journal of craniofacial surgery - 32(2021), 3 vom: 01. Mai, Seite 863-867

Sprache:

Englisch

Beteiligte Personen:

Lee, Jun Yong [VerfasserIn]
Shin, Jeonghwan [VerfasserIn]
Baek, Sang Oon [VerfasserIn]

Links:

Volltext

Themen:

Journal Article

Anmerkungen:

Date Completed 17.11.2021

Date Revised 17.11.2021

published: Print

Citation Status MEDLINE

doi:

10.1097/SCS.0000000000007059

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM315127287